A coronavirus vaccine being developed by Oxford University and the Italian firm IRBM will be tested on children and the elderly as well as in adults, sources said Friday.
The first-phase trials, which started in April, involved 1,000 adults under the age of 55.
Now another 10,200 people in the 56-69 age bracket as well as the over 70s and children between the ages of five and 12 will be enrolled in the programme. Meanwhile Rome's infectious disease hospital, the Spallanzani, said that it was testing the use of hyperimmune plasma from COVID convalescent patients, with two other Rome hospitals, the San Camillo and the Bambino Gesù, a paediatric facility.
ALL RIGHTS RESERVED © Copyright ANSA
